Clinical Study: Efficacy of Tryushnadya Churna in Metabolic Syndrome with Obesity (2024)

Purpose of the Study

This study was designed to evaluate whether an Ayurvedic herbal formulation (Tryushnadya Churna) combined with a structured Ayurveda-based diet and yoga program could improve outcomes in metabolic syndrome with obesity — a cluster of risk factors including central obesity, high blood pressure, impaired glucose metabolism, and dyslipidemia. 

Participants

Total Participants: 48 adults

Criteria: Subjects diagnosed with metabolic syndrome according to National Cholesterol Education Program (ATP III) criteria

Age Range: Not specified in abstract (adults meeting diagnostic criteria)

Randomized into two groups:

✔ Tryushnadi Churna Group — Ayurvedic herbal powder 1 g twice daily + Ayurvedic diet + yoga

✔ Placebo Group — Placebo 1 g twice daily + Ayurvedic diet + yoga

All interventions continued for 90 days. 

 Study Protocol and Measures

The researchers assessed both metabolic indicators and clinical outcomes at baseline, every 30 days, and at the end of 90 days.

Primary Measures Included

Weight & Body Mass Index (BMI)

Waist Circumference & Waist Hip Ratio

Body Fat Percentage & Skin Fold Thickness

Blood Pressure

Fasting Blood Sugar (FBS)

Glycated Hemoglobin (HbA1c)

Lipid Profile

HDL (high-density lipoprotein)

LDL (low-density lipoprotein)

Total Cholesterol (TC)

Triglycerides

Quality of Life Scores

WHO-QOL BREF scale

Clinical Global Impression (CGI) scales for severity & improvement 

 Key Findings

1. Weight & BMI

The Tryushnadi group showed a statistically significant reduction in body weight and BMI compared to the placebo group.

This suggests the formulation plus lifestyle intervention helped reduce overall obesity measures, a key component of metabolic syndrome. 

 2. Metabolic Biomarkers

Both groups (Tryushnadya + placebo with diet + yoga) showed improvements in waist circumference, body fat, and skin fold thickness when comparing pre- and post-trial values.

However, the group receiving Tryushnadya Churna exhibited larger effect sizes and more pronounced improvements, indicating the added value of the herbal formulation. 

3. Clinical Scales & Quality of Life

Subjects receiving Tryushnadya had significantly better improvements in both WHO-QOL BREF scores (quality of life) and Clinical Global Impression (CGI) scores compared to the placebo group, demonstrating enhanced perceived well-being and clinical status. 

Importance of Integrative Components

This trial didn’t test the herbal formulation in isolation. Instead, the intervention combined:

Ayurvedic herbal medicine (Tryushnadya Churna)

Ayurveda-based diet, emphasizing metabolic balance

Structured yoga practice, supporting stress regulation and physical metabolic health

This integrative design aligns with holistic approaches in lifestyle disease management — combining conventional clinical evaluation with traditional Ayurvedic therapies and lifestyle modification strategies. 

What This Study Adds to Scientific Evidence

This study contributes important clinical evidence showing that:

✔ Ayurvedic herbal formulations can have measurable metabolic and quality of life benefits when used as part of an integrative lifestyle protocol. 

✔ Structured lifestyle changes (diet + yoga) are effective in improving multiple components of metabolic syndrome — even without pharmacotherapy. 

✔ The addition of a standardized Ayurveda herbal medicine can enhance outcomes beyond diet and yoga alone, especially in obesity and lipid metabolism. 

 Limitations

While this was a well-designed and clinically rigorous trial, there are common considerations:

Sample Size: Modest (n = 48), which is typical in integrative clinical research but may limit broad generalization. 

Duration: 90 days provides strong short-term evidence, but longer studies are needed for long-term metabolic changes and chronic disease outcomes. 

Lifestyle Confounders: As both groups received diet and yoga, the isolated effect of herb vs other interventions reflects real-world integrated care rather than standalone herbal efficacy. 

Clinical Trial Registration

Unlike some older trials, more recent integrated Ayurveda clinical studies are increasingly being registered in official trial registries (e.g., CTRI) to improve scientific transparency and research reproducibility. 

Takeaway

This 2024 trial is one of the most comprehensive clinical investigations into an integrative Ayurveda-based strategy for metabolic syndrome (a major lifestyle disease cluster), showing that a combined protocol of Ayurvedic herbal therapy + diet + yoga can produce clinically significant improvements in obesity, metabolic risk markers, and overall quality of life compared to placebo